Efficacy of atomoxetine versus placebo in school-age girls with attention-deficit/hyperactivity disorder.

@article{Biederman2002EfficacyOA,
  title={Efficacy of atomoxetine versus placebo in school-age girls with attention-deficit/hyperactivity disorder.},
  author={Joseph Biederman and John Harrison Heiligenstein and Douglas E. Faries and Nora Galil and Ralf Dittmann and Graham J. Emslie and Christopher J. Kratochvil and Harry F. Laws and Kory J. Schuh},
  journal={Pediatrics},
  year={2002},
  volume={110 6},
  pages={
          e75
        }
}
OBJECTIVE The efficacy of atomoxetine was assessed in school-age girls with attention-deficit/hyperactivity disorder (ADHD). Atomoxetine is a potent inhibitor of the presynaptic norepinephrine transporter with minimal affinity for other noradrenergic receptors or for other neurotransmitter transporters or receptors. METHODS A total of 291 children who were 7 to 13 years of age and met Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition criteria for ADHD participated in 1 of… CONTINUE READING

Citations

Publications citing this paper.
SHOWING 1-10 OF 23 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-8 OF 8 REFERENCES

Similar Papers

Loading similar papers…